DE69032000D1 - Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten - Google Patents

Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten

Info

Publication number
DE69032000D1
DE69032000D1 DE69032000T DE69032000T DE69032000D1 DE 69032000 D1 DE69032000 D1 DE 69032000D1 DE 69032000 T DE69032000 T DE 69032000T DE 69032000 T DE69032000 T DE 69032000T DE 69032000 D1 DE69032000 D1 DE 69032000D1
Authority
DE
Germany
Prior art keywords
treatment
keto
cardiac dysfunction
prostaglandin derivatives
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69032000T
Other languages
English (en)
Other versions
DE69032000T2 (de
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of DE69032000D1 publication Critical patent/DE69032000D1/de
Application granted granted Critical
Publication of DE69032000T2 publication Critical patent/DE69032000T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69032000T 1989-11-22 1990-11-21 Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten Expired - Fee Related DE69032000T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30384089 1989-11-22

Publications (2)

Publication Number Publication Date
DE69032000D1 true DE69032000D1 (de) 1998-03-05
DE69032000T2 DE69032000T2 (de) 1998-05-14

Family

ID=17925938

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69032000T Expired - Fee Related DE69032000T2 (de) 1989-11-22 1990-11-21 Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten

Country Status (9)

Country Link
EP (1) EP0430551B1 (de)
JP (1) JPH0791191B2 (de)
KR (1) KR0167557B1 (de)
AT (1) ATE162717T1 (de)
CA (1) CA2030346C (de)
DE (1) DE69032000T2 (de)
DK (1) DK0430551T3 (de)
ES (1) ES2113345T3 (de)
GR (1) GR3026105T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310013T3 (es) * 1997-11-28 2008-12-16 Sucampo Ag Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina.
CZ303625B6 (cs) * 1999-10-15 2013-01-16 Sucampo Ag Stabilní farmaceutický prostredek obsahující bicyklickou slouceninu a acyglycerol, bicyklická sloucenina, zpusob stabilizace bicyklické slouceniny, farmaceutický prostredek obsahující bicyklickou slouceninu
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
KR100804525B1 (ko) 2005-03-24 2008-02-20 삼성에스디아이 주식회사 집적회로 칩용 방열부재 및 이를 구비한 디스플레이 모듈
WO2009104205A1 (en) * 2008-02-20 2009-08-27 Lupin Limited Delayed release formulation of chloride channel activator
CN102028696B (zh) * 2009-09-24 2013-02-13 上海天伟生物制药有限公司 一种***素类化合物的用途
US10457623B1 (en) 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
JPS581117B2 (ja) * 1976-01-01 1983-01-10 フアイザ−・インコ−ポレ−テツド １１−デオキシ−ω−ペンタノルプロスタグランジン類
JPS5879973A (ja) * 1981-11-09 1983-05-13 Ono Pharmaceut Co Ltd プロスタグランジン誘導体の重合体、その製造方法及び該重合体を有効成分として含有する治療剤
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
JP2760514B2 (ja) * 1988-07-20 1998-06-04 株式会社 上野製薬応用研究所 循環機能昂進剤
ES2055051T3 (es) * 1988-05-23 1994-08-16 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea.

Also Published As

Publication number Publication date
KR0167557B1 (ko) 1999-01-15
EP0430551B1 (de) 1998-01-28
CA2030346A1 (en) 1991-05-23
GR3026105T3 (en) 1998-05-29
EP0430551A2 (de) 1991-06-05
EP0430551A3 (en) 1992-07-15
JPH03218314A (ja) 1991-09-25
DK0430551T3 (da) 1998-04-14
JPH0791191B2 (ja) 1995-10-04
KR910009270A (ko) 1991-06-28
ES2113345T3 (es) 1998-05-01
ATE162717T1 (de) 1998-02-15
DE69032000T2 (de) 1998-05-14
CA2030346C (en) 2000-04-11

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH

8339 Ceased/non-payment of the annual fee